Yong‐ju Liang - Concepedia

Concepedia

Author

Yong‐ju Liang

Sun Yat-sen University Cancer Center

Also Known As

Yong-Ju Liang, Yong-ju LIANG, Yong-ju Liang, Yong‐Ju Liang, Yong‐ju Liang

43

Publications

2.6K

Citations

28

H-Index

56

Concepts

All Affiliations

Sun Yat-sen University Cancer Center Sun Yat-sen University State Key Laboratory of Oncology in South China St. John's University Central China Normal University

YL

About

Yong‐ju Liang is an author at Sun Yat-sen University Cancer Center specializing in medicine, pharmacology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	19	1.3K
2	Natural Sciences	5	5	466
3	Health Sciences	2	2	164
4	Biochemistry	2	2	397
5	Engineering	1	1	15

Yong‐ju Liang

×

38

Publications

2.6K

Citations

28

H-Index

	Year	Citations
Lapatinib (Tykerb, GW572016) Reverses Multidrug Resistance in Cancer Cells by Inhibiting the Activity of ATP-Binding Cassette Subfamily B Member 1 and G Member 2 Chun-ling Dai, Amit K. Tiwari, Chung‐Pu Wu, Cancer Research	2008	381
Apatinib (YN968D1) Reverses Multidrug Resistance by Inhibiting the Efflux Function of Multiple ATP-Binding Cassette Transporters Yan‐jun Mi, Yong‐ju Liang, Hong-Bing Huang, Cancer Research Chemoprevention StrategyMolecular BiologyMultidrug ResistanceTumor BiologyAbcg2 Protein	2010	346
Reversal of MDR1/P-glycoprotein-mediated multidrug resistance by vector-based RNA interference in vitro and in vivo Zhi Shi, Yong‐ju Liang, Zhe‐Sheng Chen, Cancer Biology & Therapy Mdr1 MrnaMolecular BiologyMdr1/p-glycoprotein-mediated Multidrug ResistanceCancer BiologyTumor Biology	2006	140
Sensitization of ABCG2-overexpressing cells to conventional chemotherapeutic agent by sunitinib was associated with inhibiting the function of ABCG2 Chun-ling Dai, Yong‐ju Liang, Yan-sheng Wang, Cancer Letters MedicinePhotocarcinogenesisMechanism Of ActionCell DeathAbcg2-overexpressing Cells	2009	117
Apatinib (YN968D1) enhances the efficacy of conventional chemotherapeutical drugs in side population cells and ABCB1-overexpressing leukemia cells Xiu-zhen Tong, Fang Wang, Shu-Ling Liang, Biochemical Pharmacology Hematological MalignancyTumor BiologyConventional Chemotherapeutical DrugsMedicinePharmacology	2011	116
Secalonic Acid D induced leukemia cell apoptosis and cell cycle arrest of G1 with involvement of GSK-3β/β-catenin/c-Myc pathway Jianye Zhang, Li-yang Tao, Yong‐ju Liang, Cell Cycle	2009	109
Anthracenedione Derivatives as Anticancer Agents Isolated from Secondary Metabolites of the Mangrove Endophytic Fungi Jianye Zhang, Li-yang Tao, Yong‐ju Liang, Marine Drugs	2010	102
Crizotinib (PF‐02341066) reverses multidrug resistance in cancer cells by inhibiting the function of P‐glycoprotein Wenjing Zhou, Xu Zhang, Chao Cheng, British Journal of Pharmacology	2012	101
Neratinib Reverses ATP-Binding Cassette B1-Mediated Chemotherapeutic Drug Resistance In Vitro, In Vivo, and Ex Vivo Xiao-qin Zhao, Jing‐Dun Xie, Xing-gui Chen, Molecular Pharmacology	2012	92
Vandetanib (Zactima, ZD6474) Antagonizes ABCC1- and ABCG2-Mediated Multidrug Resistance by Inhibition of Their Transport Function Li-Sheng Zheng, Fang Wang, Yuhong Li, PLoS ONE	2009	88

Page 1